We investigate the concordance, in terms of favoring the same treatment arm, between clinician-reported symptomatic adverse events (AEs) and information obtained via patient-reported outcomes (PRO) measures in cancer randomized controlled trials (RCTs).
Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes? / Sparano, F., Aaronson, N.K., Cottone, F., Piciocchi, A., La Sala, E., Anota, A., Deliu, N., Kieffer, J.M., Efficace, F.. - In: JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH. - ISSN 2042-6305. - 8:5(2019), pp. 279-288. [10.2217/cer-2018-0092]
Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes?
Cottone, Francesco;Piciocchi, Alfonso;Deliu, NinaMethodology
;Efficace, Fabio
2019
Abstract
We investigate the concordance, in terms of favoring the same treatment arm, between clinician-reported symptomatic adverse events (AEs) and information obtained via patient-reported outcomes (PRO) measures in cancer randomized controlled trials (RCTs).File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Deliu_Clinician-reported_2019.pdf.pdf
solo gestori archivio
Note: Deliu_Clinician-reported_2019.pdf
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
942.03 kB
Formato
Adobe PDF
|
942.03 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
